ライフサイエンスコーパス: breast implant

1 rtificial cavity related to the capsule of a breast implant.

2 nt in samples from women exposed to silicone breast implants.

3 es from women exposed to silicone and saline breast implants.

4 should always use closed systems to inflate breast implants.

5 restricted to studies of silicone-gel-filled breast implants.

6 e-tissue disease that could be attributed to breast implants.

7 occurred years ago in women with and without breast implants.

8 st 5 years before baseline, and did not have breast implants.

9 ures are an important problem for women with breast implants.

10 the long-term health consequences of having breast implants.

11 ion women in the United States have silicone breast implants.

12 connective-tissue diseases among women with breast implants.

13 nated by studies on the role of silicone gel breast implants.

14 isks of connective-tissue diseases following breast implants.

15 ear trends in RR with increasing duration of breast implants.

16 seem to be increased in women with silicone breast implants.

17 who currently have or are seeking to obtain breast implants about the overall risk of these devices.

18 A total of 10,830 women reported breast implants and 11,805 reported connective-tissue di

19 960-1996), 351 (4.8%) of 7,234 patients with breast implants and 62 (2.9%) of 2,138 patients who had

20 ufficient to rule out an association between breast implants and connective tissue disease-like syndr

21 ot confirmed an association between silicone breast implants and connective tissue diseases, a conclu

22 Evidence on breast implants and other outcomes either was limited or

23 the unexpected relationship between cosmetic breast implants and suicide that has been found in six e

24 The postulated relation between silicone breast implants and the risk of connective-tissue and au

25 From a public health perspective, breast implants appear to have a minimal effect on the n

26 Most patients with breast implant-associated ALCL who had disease confined

27 Breast implant-associated anaplastic large cell lymphoma

28 Breast implant-associated anaplastic large cell lymphoma

29 Breast implant-associated anaplastic large-cell lymphoma

30 sted County, Minnesota, and received a first breast implant at the Mayo Clinic between 1964 and 1991.

31 l lymphoma is a rare cancer in patients with breast implants but is increasing in incidence.

32 has greatly increased in women with silicone breast implants, but no studies have ruled out a moderat

33 imates for any definite CTD among women with breast implants compared with women without breast impla

34 idence that the urine of women with silicone breast implants contain 60 to over 1700 times more plati

35 f female CD-1 mice were injected with either breast implant distillate composed primarily of hexameth

36 The authors identified 220 women with breast implants (exposed) who self-reported CTD and a ra

37 Saline breast implant fluid (n = 2) did not contain detectable

38 Pt in explanted silicone breast implant gel (n = 9) occurred mainly in the +2, +4

39 Silicone-gel-filled breast implants have been widely used for breast augment

40 date, to show that women exposed to silicone breast implants have Pt levels that exceed that of the g

41 the liver of women with silicone gel-filled breast implants helped measure silicone exposure.

42 re was no evidence of an association between breast implants in general, or silicone-gel-filled breas

43 The risk of having breast implants in those patients with early symptoms of

44 suicide rate of women who received cosmetic breast implants is approximately twice the expected rate

45 hypothesis that the presence of bacteria on breast implants is associated with capsular contracture.

46 mples (n = 6) from women exposed to silicone breast implants occurred mainly in the +2 and +4 oxidati

47 sediment was noted in saline-filled silicone breast implants of women who had undergone revision surg

48 ndrome (TOS) secondary to sports activities, breast implants, or median sternotomy.

49 cooking oils, L-tryptophan, silica, silicone breast implants, organic solvents, and other agents such

50 that the platinum used in the manufacture of breast implants (Pt0) is converted by a unknown process

51 antibodies was found in symptomatic silicone breast implant recipients who often have fibromyalgia.

52 ntration of silicon in the blood of silicone breast implant recipients, as determined by ICP analysis

53 lective participation by affected women with breast implants remains a plausible alternative explanat

54 y studied consecutive patients who underwent breast implant removal for reasons other than overt infe

55 r after placement of silicone gel-containing breast implants (SBI).

56 implants in general, or silicone-gel-filled breast implants specifically, and any of the individual

57 nces we found between women with and without breast implants suggest that consideration and evaluatio

58 stress injury, the side effects of silicone breast implants, the Gulf War syndrome, chronic whiplash

59 Compared with women who did not report breast implants, the relative risk (RR) of the combined

60 icians involved in the care of patients with breast implants to be aware of this entity and be able t

61 nd Drug Administration changed the status of breast implants to investigational.

62 CTD and a random sample of 879 women without breast implants (unexposed) who also self-reported CTD,

63 ected suicide rate among women with cosmetic breast implants warrants further research.

64 tive-tissue disease among those who reported breast implants was 1.24 (95% confidence interval, 1.08

65 ed that the rate of suicide among women with breast implants was greater than that of women who under

66 The odds ratio for exposure to breast implants was increased, but not significantly (OR

67 on in samples from women exposed to silicone breast implants were as follows: whole blood, 568.1 +/-

68 There was no evidence that breast implants were associated with a significant incre

69 Women with breast implants were more likely to drink a greater aver

70 Removed breast implants were processed using a vortexing/sonicat

71 Silicone gel breast implants were removed from the U.S. market for co

72 female health professionals with and without breast implants who reported CTD on mailed questionnaire

73 breast implants compared with women without breast implants would be similar in analyses of self-rep

74 nusual Brucella strain (BO1) isolated from a breast implant wound in a 71-year-old woman with clinica